Login
|
New Account
AAAAAA
ITA
ENG
Results:
1-20
|
Table of contents of journal:
Results: 20
An overview of adjuvant use
Authors:
Edelman, R
Citation:
R. Edelman, An overview of adjuvant use, METH MOL M, 42, 2000, pp. 1-27
Harmful and beneficial activities of immunological adjuvants
Authors:
Stewart-Tull, DES
Citation:
Des. Stewart-tull, Harmful and beneficial activities of immunological adjuvants, METH MOL M, 42, 2000, pp. 29-48
Freund's adjuvants
Authors:
Lindblad, EB
Citation:
Eb. Lindblad, Freund's adjuvants, METH MOL M, 42, 2000, pp. 49-63
Aluminum compounds as vaccine adjuvants
Authors:
Gupta, RK Rost, BE
Citation:
Rk. Gupta et Be. Rost, Aluminum compounds as vaccine adjuvants, METH MOL M, 42, 2000, pp. 65-89
Poly(lactide-coglycolide) microparticles as vaccine adjuvants
Authors:
O'Hagan, DT Singh, M
Citation:
Dt. O'Hagan et M. Singh, Poly(lactide-coglycolide) microparticles as vaccine adjuvants, METH MOL M, 42, 2000, pp. 91-103
Poly(methyl methacrylate) nanoparticles as vaccine adjuvants
Authors:
Kreuter, J
Citation:
J. Kreuter, Poly(methyl methacrylate) nanoparticles as vaccine adjuvants, METH MOL M, 42, 2000, pp. 105-119
Aqueous formulation of adjuvant-active nonionic block copolymers
Authors:
Todd, CW Newman, MJ
Citation:
Cw. Todd et Mj. Newman, Aqueous formulation of adjuvant-active nonionic block copolymers, METH MOL M, 42, 2000, pp. 121-136
Liposomes as immunological adjuvants and vaccine carriers
Authors:
Gregoriadis, G McCormack, B Obrenovic, M Perrie, Y Saffie, R
Citation:
G. Gregoriadis et al., Liposomes as immunological adjuvants and vaccine carriers, METH MOL M, 42, 2000, pp. 137-150
Immunopotentiating reconstituted influenza virosomes (IRIVs)
Authors:
Gluck, R
Citation:
R. Gluck, Immunopotentiating reconstituted influenza virosomes (IRIVs), METH MOL M, 42, 2000, pp. 151-178
Cochleates for induction of mucosal and systemic immune responses
Authors:
Gould-Fogerite, S Mannino, RJ
Citation:
S. Gould-fogerite et Rj. Mannino, Cochleates for induction of mucosal and systemic immune responses, METH MOL M, 42, 2000, pp. 179-196
Virus-like particles as vaccine adjuvants
Authors:
Gilbert, SC
Citation:
Sc. Gilbert, Virus-like particles as vaccine adjuvants, METH MOL M, 42, 2000, pp. 197-209
The adjuvant MF59: A 10-year perspective
Authors:
Ott, G Radhakrishnan, R Fang, JH Hora, M
Citation:
G. Ott et al., The adjuvant MF59: A 10-year perspective, METH MOL M, 42, 2000, pp. 211-228
Preparation of the Syntex adjuvant formulation (SAF, SAF-m, SAF-1)
Authors:
Lidgate, DM
Citation:
Dm. Lidgate, Preparation of the Syntex adjuvant formulation (SAF, SAF-m, SAF-1), METH MOL M, 42, 2000, pp. 229-237
The ISCOM (TM) technology
Authors:
Lovgren-Bengtsson, K Morein, B
Citation:
K. Lovgren-bengtsson et B. Morein, The ISCOM (TM) technology, METH MOL M, 42, 2000, pp. 239-258
QS-21 adjuvant
Authors:
Kensil, CR
Citation:
Cr. Kensil, QS-21 adjuvant, METH MOL M, 42, 2000, pp. 259-271
MPL (R) immunostimulant: Adjuvant formulations
Authors:
Ulrich, JT
Citation:
Jt. Ulrich, MPL (R) immunostimulant: Adjuvant formulations, METH MOL M, 42, 2000, pp. 273-282
Cytokines as vaccine adjuvants: The use of interleukin-2
Authors:
Giedlin, MA
Citation:
Ma. Giedlin, Cytokines as vaccine adjuvants: The use of interleukin-2, METH MOL M, 42, 2000, pp. 283-297
DNA as an adjuvant
Authors:
Neujahr, DC Pisetsky, DS
Citation:
Dc. Neujahr et Ds. Pisetsky, DNA as an adjuvant, METH MOL M, 42, 2000, pp. 299-313
Transcutaneous immunization
Authors:
Glenn, GM Scharton-Kersten, T Vassell, R
Citation:
Gm. Glenn et al., Transcutaneous immunization, METH MOL M, 42, 2000, pp. 315-326
Mutant heat-labile enterotoxins as adjuvants for CTL induction
Authors:
Neidleman, JA Ott, G O'Hagan, D
Citation:
Ja. Neidleman et al., Mutant heat-labile enterotoxins as adjuvants for CTL induction, METH MOL M, 42, 2000, pp. 327-336
Risultati:
1-20
|